 increas frequenc cervic dysplasia-neoplasia women human immunodefici viru degre immunosuppress cytolog histolog investig uterin cervix studi lymphocyt function human immunodefici virus-infect human immunodefici viru antibody-neg women possibl linkag human papillomavirus-induc dysplasia degre human immunodefici virus-induc immunosuppress cytolog smear uterin cervix human immunodefici virus-infect women find femal intraven drug user human immunodefici viru antibodi group women outpati popul hospit cervic dysplasia-neoplasia case invas carcinoma human immunodefici virus-infect patient human immunodefici virus-neg intraven drug user dysplasia-neoplasia sampl outpati case invas carcinoma cytolog attribut human papillomaviru human immunodefici virus-infect women time sampl outpati popul frequenc sever dysplasia number helper/induc loss blastogen respons mitogen tetanu toxoid result risk develop dysplasia uterin cervix women human immunodefici viru infect degre immunosuppress